ZFZheng-Zhong Feng

Zheng-Zhong Feng

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Zheng-Zhong Feng has a total of 7 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Hypoxia-Induced Snail Expression Through Transcriptional Regulation by HIF-1α in Pancreatic Cancer Cells

    by Guang-Hui Zhu, Chen Huang, Zheng-Zhong Feng, Xiu-Hong Lv, Zheng-Jun Qiu

    Background Intratumoral hypoxia and epithelial–mesenchymal transition are involved in tumor invasion and metastasis. Aims This study investigated the molecular mechanisms that relay the hypoxia signal into the epithelial–mesenchymal transition and metastasis. Methods Morphology analysis and tumor cell migration and invasion assays were performed to detect phenotypic changes of pancreatic cancer cells under normoxic and hypoxic conditions after lentiviral HIF-1α shRNA transfection. Quantitative reverse transcription polymerase chain reaction, western blot, and immunohistochemistry were used to detect gene expression in pancreatic cancer cell lines and tissues or normal pancreatic tissues. Luciferase, gel shift, and ChIP assays were used to assess gene regulation. Results Under hypoxic conditions, these tumor cells underwent typical morphological and molecular changes to epithelial–mesenchymal transition. Moreover, Snail expression was induced by hypoxic conditions and was regulated by HIF-1α expression at the transcriptional level through HIF-1α-binding to the second site of hypoxia-responsive elements of the Snail gene promoter. In addition, Snail expression was associated with HIF-1α expression in pancreatic cancer tissues, and expression of both was associated with tumor metastasis and poor patient survival. Conclusions Our study provides key evidence that HIF-1α and Snail are responsible for hypoxia-induced metastasis phenotypes in pancreatic cancer and that HIF-1α and Snail expression can be used as biomarkers to predict tumor metastasis and patient survival.


  • Expression and Prognostic Significance of CD151, c-Met, and Integrin alpha3/alpha6 in Pancreatic Ductal Adenocarcinoma

    by Guang-Hui Zhu, Chen Huang, Zheng-Jun Qiu, Jun Liu, Zhi-Hua Zhang, Ning Zhao, Zheng-Zhong Feng, Xiu-Hong Lv

    CD151, c-Met, and integrin alpha3/alpha6 are all involved in the hepatocyte growth factor (HGF)/c-Met signal pathway, which plays an important role in the malignant progression of tumors. The purpose of this study was to explore the expression and prognostic significance of these proteins in pancreatic ductal adenocarcinoma (PDAC). We used immunohistochemical methods to investigate the expression patterns of CD151, c-Met, and integrin alpha3/alpha6proteins in 71 patients with PDAC and in ten samples of normal pancreatic tissue. We also assessed correlations between these proteins and clinicopathological parameters and survival of PDAC patients using various statistical methods. CD151, c-Met, and integrin alpha3/alpha6 were all overexpressed in PDAC. CD151 and c-Met overexpressions were significantly associated with TNM stage (p = 0.001 and p = 0.038, respectively) and lymph node invasion (p = 0.000, p = 0.012, respectively). A significant positive linear correlation was found between CD151 and c-Met (r = 0.583; p = 0.000), integrin alpha3 (r = 0.457; p = 0.000), and integrin alpha6 (r = 0.671; p = 0.000). Overexpression of CD151, c-Met, integrin alpha3, or integrin alpha6 was related to poor survival of PDAC patients (p = 0.000, p = 0.000, p = 0.005, and p = 0.003, respectively), and CD151 and c-Met were independent factors in prognosis of PDAC. CD151, c-Met, and integrin alpha3/alpha6 were all overexpressed in PDAC. CD151 and c-Met might be new molecular markers to predict the prognosis of PDAC patients.